StockNews.com Initiates Coverage on Intra-Cellular Therapies (NASDAQ:ITCI)
Analysts at StockNews.com initiated coverage on shares of Intra-Cellular Therapies (NASDAQ:ITCI – Get Free Report) in a report released on Sunday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Several other equities research analysts also recently commented on the stock. Baird R W downgraded shares of Intra-Cellular Therapies from a “strong-buy” rating […]
More Stories
McCormick & Company, Incorporated (NYSE:MKC) and Top Wealth Group (NASDAQ:TWG) Head-To-Head Contrast
Top Wealth Group (NASDAQ:TWG – Get Free Report) and McCormick & Company, Incorporated (NYSE:MKC – Get Free Report) are both...
Celsius Holdings, Inc. (NASDAQ:CELH) Receives $45.00 Average Price Target from Brokerages
Shares of Celsius Holdings, Inc. (NASDAQ:CELH – Get Free Report) have received a consensus rating of “Moderate Buy” from the...
Comparing ZEEKR Intelligent Technology (ZK) & Its Peers
ZEEKR Intelligent Technology (NYSE:ZK – Get Free Report) is one of 77 public companies in the “Motor vehicles & car...
Critical Contrast: Century Therapeutics (NASDAQ:IPSC) vs. Omega Therapeutics (NASDAQ:OMGA)
Omega Therapeutics (NASDAQ:OMGA – Get Free Report) and Century Therapeutics (NASDAQ:IPSC – Get Free Report) are both small-cap medical companies,...
Analysts Set Kite Realty Group Trust (NYSE:KRG) Price Target at $27.88
Shares of Kite Realty Group Trust (NYSE:KRG – Get Free Report) have been assigned a consensus rating of “Moderate Buy”...
Denison Mines (NYSEAMERICAN:DNN) Earns Buy Rating from Analysts at Desjardins
Desjardins began coverage on shares of Denison Mines (NYSEAMERICAN:DNN – Free Report) (TSE:DML) in a research report report published on...